Skip to main content
Fig. 4 | BMC Pulmonary Medicine

Fig. 4

From: MIR205HG acts as a ceRNA to expedite cell proliferation and progression in lung squamous cell carcinoma via targeting miR-299-3p/MAP3K2 axis

Fig. 4

MIR205HG accelerated LUSC development by modulating miR-299-3p/MAP 3 K2 signaling. a. Colony formation assay was applied to detect cell proliferation capacity in both cells by transfection with sh-MIR205HG#1 and pcDNA3.1/MAP 3 K2. b. Cell apoptosis rate was tested via flow cytometry analysis. c. Cell migration capacity was estimated through conducting transwell assay. d. EMT-related protein level was evaluated by western blot analysis. All data were expressed as the mean ± SD. **P < 0.01

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us